Business
USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference
USRM Chief Science Officer to Present at Academy of Regenerative Practices Conference.
About this update from U.s. Stem Cell, Inc.
[{"type":"text","content":"\n\n\n\nUSRM Chief Science Officer to Present at Academy of Regenerative Practices Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nUSRM Chief Science Officer to Present at Academy of Regenerative Practices Conference\nPR Newswire\nSUNRISE, Fla., Feb. 28, 2018\n\n\n\nSUNRISE, Fla., Feb. 28, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, announces our participation in this year's fourth annual Academy of Regenerative Practices' Conference, which kicks off tomorrow and continues through March 2 & 3 at the Bonaventure Resort & Spa in Weston, Florida.\n\n\n \n \n\n \nThe Conference, which hosts some of the world's leading regenerative scientists, health and medical professionals -- including USRM's Chief Science Officer & ARP President Dr. Kristin Comella -- will feature more than 29 speakers including Dr. Joseph Mercola, Dr. Josh Axe & Ben Greenfield.\n\nThe annual event also provides doctors and physicians the opportunity to receive hands-on, accredited, continuing education training in performing stem cell procedures.  Doctors are able to gain the ability to augment their practice with this cutting-edge, regenerative therapy -- a process that is becoming increasingly in demand amongst the patient population in the United States suffering from neurological, autoimmune, orthopedic and degenerative conditions.\n\nDr. Comella will be presenting a summary of peer-reviewed publications using a stem cell procedure called Stromal Vascular Fraction (SVF), on Saturday, March 3, at 8:40 a.m.  She is well published in the scientific literature through her work at USRM on the application of stem cells and regenerative therapy, including integrating stem cells to improve knee function in cartilage damaged by osteoarthritis; a phase I clinical trial for the use of autologous stem cells in the treatment of end-stage chronic obstructive pulmonary disease; intraglandular injection of stem cells for the treatment of irrad...